Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone

References

• Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012;35:155–69.
   PubMed Web of Science ®Google Scholar
• Lindvall P, Koskinen LO. Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 2009;16:1287–90.
   PubMed Web of Science ®Google Scholar
• Aspegren OP, Astrand R, Lundgren MI, Romner B. Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 2013;115:981–4.
   PubMed Web of Science ®Google Scholar
• Moskala M, Goscinski I, Kaluza J, et al. Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies. Microsc Microanal 2007;13:211–19.
   PubMed Web of Science ®Google Scholar
• Ernestus RI, Beldzinski P, Lanfermann H, Klug N. Chronic subdural hematoma: surgical treatment and outcome in 104 patients. Surg Neurol 1997;48:220–5.
   PubMedGoogle Scholar
• Kwon TH, Park YK, Lim DJ, et al. Chronic subdural hematoma: evaluation of the clinical significance of postoperative drainage volume. J Neurosurg 2000;93:796–9.
   PubMed Web of Science ®Google Scholar
• Torihashi K, Sadamasa N, Yoshida K, et al. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 2008;63:1125–9.
   PubMed Web of Science ®Google Scholar
• Jung YG, Jung NY, Kim E. Independent predictors for recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 2015;57:266–70.
   PubMed Web of Science ®Google Scholar
• Schwarz F, Loos F, Dunisch P, et al. Risk factors for reoperation after initial burr hole trephination in chronic subdural hematomas. Clin Neurol Neurosurg 2015;138:66–71.
   PubMed Web of Science ®Google Scholar
• Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 2001;95:256–62.
   PubMed Web of Science ®Google Scholar
• El-Kadi H, Miele VJ, Kaufman HH. Prognosis of chronic subdural hematomas. Neurosurg Clin N Am 2000;11:553–67.
   PubMed Web of Science ®Google Scholar
• Foelholm R, Waltimo O. Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien) 1975;32:247–50.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 2003;98:1217–21.
   PubMed Web of Science ®Google Scholar
• Stanisic M, Lyngstadaas SP, Pripp AH, et al. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir (Wien) 2012;154:113–20.
   PubMed Web of Science ®Google Scholar
• Fujisawa H, Ito H, Saito K, et al. Immunohistochemical localization of tissue-type plasminogen activator in the lining wall of chronic subdural hematoma. Surg Neurol 1991;35:441–5.
   PubMedGoogle Scholar
• Glover D, Labadie EL. Physiopathogenesis of subdural hematomas. Part 2: inhibition of growth of experimental hematomas with dexamethasone. J Neurosurg 1976;45:393–7.
   PubMed Web of Science ®Google Scholar
• Labadie EL, Glover D. Physiopathogenesis of subdural hematomas. Part 1: histological and biochemical comparisons of subcutaneous hematoma in rats with subdural hematoma in man. J Neurosurg 1976;45:382–92.
   PubMed Web of Science ®Google Scholar
• Santarius T, Lawton R, Kirkpatrick PJ, Hutchinson PJ. The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland. Br J Neurosurg 2008;22:529–34.
   PubMed Web of Science ®Google Scholar
• Sun TF, Boet R, Poon WS. Non-surgical primary treatment of chronic subdural haematoma: preliminary results of using dexamethasone. Br J Neurosurg 2005;19:327–33.
   PubMed Web of Science ®Google Scholar
• Thotakura AK, Marabathina NR. Nonsurgical treatment of chronic subdural hematoma with steroids. World Neurosurg 2015;84:1968–72.
   PubMed Web of Science ®Google Scholar
• Dran G, Berthier F, Fontaine D, et al. Effectiveness of adjuvant corticosteroid therapy for chronic subdural hematoma: a retrospective study of 198 cases. Neurochirurgie 2007;53:477–82.
   PubMed Web of Science ®Google Scholar
• Nomura S, Kashiwagi S, Fujisawa H, et al. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot. J Neurosurg 1994;81:910–13.
   PubMed Web of Science ®Google Scholar
• Kitazono M, Yokota H, Satoh H, et al. Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. Neurol Med Chir (Tokyo) 2012;52:810–15.
   PubMed Web of Science ®Google Scholar
• Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 2004;100:24–32.
   PubMed Web of Science ®Google Scholar